Stock listing
NASDAQ:TSRX Trius Therapeutics Inc Stock
Follow Trius Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:TSRX
$13.63 USD
Close on Sep 11, 2013 · No longer trades
- Lowest – highest close
- $3.02 – $14.10 USDSince Aug 3, 2010 · lowest Dec 6, 2010 · highest Jul 31, 2013
Delisted NASDAQ:TSRX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:TSRX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Trius Therapeutics Inc on 6ix
- Decks
- 2 decks · latest Mar 25, 2013
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (March 2013) | Technical | 15 slides | Mar 25, 2013 |
| Corporate Update (January 2012) | Corporate update | 13 slides | Jan 3, 2012 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Theodore R Schroeder Other companies: Phathom Pharmaceuticals, Inc. (Director · Since at least Apr 16, 2025); Cidara Therapeutics Inc (Director · Since at least Apr 14, 2015); Nabriva Therapeutics AG (Director · Jul 24, 2018 – Jan 29, 2023 · Past); Collegium Pharmaceutical, Inc. (Director · Jan 22, 2016 – May 20, 2020 · Past); Otonomy Inc (Director · Aug 28, 2015 – Jun 21, 2022 · Past); Hyperion Therapeutics Inc (Director · Aug 11, 2014 – May 7, 2015 · Past); Cadence Pharmaceuticals Inc (President, CEO, Director · Oct 24, 2006 – Mar 19, 2014 · Past) | Director · Aug 2, 2010 – Sep 11, 2013 · Past |
| John Craig Thompson Other companies: Esperion Therapeutics, Inc. (Director · Since at least Jul 1, 2025); Anthera Pharmaceuticals Inc (President & CEO, Director · Jan 7, 2016 – Jan 5, 2018 · Past); Tetraphase Pharmaceuticals Inc (Chief Operating Officer · Feb 3, 2014 – Sep 8, 2015 · Past) | Chief Commercial Officer · Mar 8, 2012 – Sep 11, 2013 · Past |
| Matthew Onaitis Other companies: Cidara Therapeutics Inc (Gnrl Counsel, CFO & Secretary · Jul 1, 2016 – Mar 29, 2018 · Past); Somaxon Pharmaceuticals Inc (SVP, General Counsel · May 15, 2006 – Dec 31, 2012 · Past) | General Counsel · May 31, 2012 – Sep 11, 2013 · Past |
Log in to ask 6ix AI your own questions about Trius Therapeutics Inc.